BRIDGEWATER, N.J., Nov. 3, 2021 /PRNewswire/ -- Insmed
Incorporated Inc. (Nasdaq: INSM), a global biopharmaceutical
company on a mission to transform the lives of patients with
serious and rare diseases, today announced that management will
participate in the following virtual investor conferences:
- The Credit Suisse 30th Annual Virtual Healthcare
Conference on November 9, 2021 at
10:30 a.m. ET in a fireside chat
- The Stifel 2021 Virtual Healthcare Conference on November 17, 2021 at 8:40
a.m. ET in a fireside chat
- The Evercore ISI 4th Annual HealthCONx Virtual
Conference on November 30, 2021 at
8:00 a.m. ET in a fireside chat
Each fireside chat will be webcast live and can be accessed by
visiting the investor relations section of the Company's website at
www.insmed.com. Each webcast will be archived for a period of 30
days following the conclusion of each live event.
About Insmed
Insmed Incorporated is a global
biopharmaceutical company on a mission to transform the lives of
patients with serious and rare diseases. Insmed's first commercial
product is a first-in-disease therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung
disease. The Company is also progressing a robust pipeline of
investigational therapies targeting areas of serious unmet need,
including neutrophil-mediated inflammatory diseases and rare
pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a growing
footprint across Europe and in
Japan. For more information, visit
www.insmed.com.
Contact:
Investors:
Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
eleanor.barisser@insmed.com
Media:
Mandy Fahey
Senior Director, Corporate Communications
Insmed
(732) 718-3621
amanda.fahey@insmed.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/insmed-to-participate-in-three-november-conferences-301414353.html
SOURCE Insmed Incorporated